Senators question Allergan CEO on tribe patent deal
Por um escritor misterioso
Descrição
A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.
CONTROVERSIAL STRATEGY: SELLING PATENTS TO A NATIVE AMERICAN TRIBE
Speaker Biographies and Faculty - Scope Summit
Allergan deal with Mohawk tribe casts patent shadow
Supreme Court case could deal a blow to Mohawk tribe's patent plan
A handful of Allergan's top shareholders want to bring back the old CEO as chairman
Allergan's Mohawk Tribe Patent Defense Is Eyewash - Court
Durotep MT, Radio Compass Blog, Latest Pharmaceutical Articles
Senators blast Allergan's tribal deal, social contract as 'hypocrisy
Prescription Drug Costs
U.S. Supreme Court rejects Allergan bid to use tribe to shield drug patents
A handful of Allergan's top shareholders want to bring back the old CEO as chairman
de
por adulto (o preço varia de acordo com o tamanho do grupo)
